Raltegravir (n=9) Atazanvir/r (n=8) p-value
Race      
African American 5 (56%) 5 (63%) 0.77*
Hispanic 3 (33%) 1 (13%)  
Caucasian 1 (11%) 1 (25%)  
Asian 0 (0%) 1 (13%)  
Gender      
Male 6 (67%) 6 (75%) 1.00*
Female 3 (33%) 2 (25%)  
Drug Screen/Drug Use      
Positive 5 (56%) 2 (25%) 0.33*
Age (yr) 42.8 (13.2) 43.8 (8.5) 0.85
* Fisher’s exact test
Table 3: Demographics of those who completed week 48 visit.